By Bhanvi Satija LONDON, Oct 6 (Reuters) – AI-based medical devices will need constant monitoring even after they're approved for use, rather than a single pre-approval safety check, the head of the
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
France come from behind to thrash Belgium 4-1
VIDEO SHOWS: POST-MATCH PRESS CONFERENCES WITH FRANCE COACH ZINEDINE ZIDANE AND BELGIUM COACH MARK VAN…
Oct 5 (Reuters) - The Greenbrier Companies, Inc. : * GREENBRIER RESPONDS TO TRADE PETITION…
Australia's ABC rejects AI copyright carveout, believes already been scraped
SYDNEY, Oct 6 (Reuters) - The Australian national broadcaster rejected a suggestion on Tuesday that…
